Ensysce Biosciences Inc (NAS:ENSC)
$ 8.88 -0.48 (-5.13%) Market Cap: 12.21 Mil Enterprise Value: 8.93 Mil PE Ratio: 0 PB Ratio: 1.22 GF Score: 36/100

Q3 2022 Ensysce Biosciences Inc Earnings Call Transcript

Nov 16, 2022 / 04:00PM GMT
Release Date Price: $502.2 (+29.17%)
Operator

Good morning and welcome to the Ensysce Biosciences, Inc. corporate update call. As a reminder, this conference is being recorded. Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer; Dr. Bill Schmidt, Chief Medical Officer; and Dave Humphrey, Chief Financial Officer.

Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially.

You're cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events.

Throughout today's discussion, we will attempt to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot